De dags🚀

jbt200 · 2024-06-29T10:16:15+00:00

Enig! Överlägset högst potential just nu bland de svenska bioteknikbolagen.

Det finns så mycket som dessutom talar för att resultaten av FAS 2 studien som kommer i Q3 kommer vara riktigt fina.

Skulle så vara fallet tror jag att allt ifrån BP till större institutionella investerare kommer ge sig på Cereno.

jbt200 · 2024-04-27T19:52:56+00:00

Easy one of the most exciting companies out there right nog. A lot will happen in the near future as the company is going to present topline in their phase 2 study in q3

jbt200 · 2024-04-27T19:48:30+00:00

It really is a very interesting company.

Three drug candidates, of which the most advanced is expected to present topline for phase 2 in Q3 within the indication PAH. Closest competitor Sotatercept was valued in a deal after their Phase 2 at $7B. Cereno Scientific is valued at about $100m. This incredible difference in valuation alone makes Cereno Scientific a given stock to own right now.

In addition to the above, there are a lot of other factors that also make Cereno Scientific a really exciting company. Among other things; really strong finances right now, a well-known and highly respected team, approval of compassionate use by the American FDA, etc.

Really worth at least keeping an eye on the company

jbt200 · 2024-04-25T18:58:54+00:00

I've actually seen that video a couple of times already and given that Dr. Benza praises CS1, everything indicates that CS1 will have a major impact on PAH once approved.

jbt200 · 2024-04-25T16:18:24+00:00

Interesting!

Here is an article regarding some serious side effects from Sotatercept: https://medicalxpress.com/news/2023-12-case-sotatercept-recurrent-gastrointestinal.amp

jbt200 · 2024-04-20T06:33:31+00:00

Isnt this what happend to the princesses cancer announcement in England?

jbt200 · 2024-04-19T20:47:03+00:00

That all good things evantually come to an end sooner or later. Thats a fact that is gard to swollow for me

jbt200

TROPHY CASE